Predicting the position of pIOLs

Article

Predicting the position of an iris-fixated pIOL is important to ensure intraocular structure health is maintained. In this article, Dr Soltani Moghadam describes his recent study that found AS-OCT imaging technique to be particularly useful as a preoperative simulation technique.

Regarding endothelial cell health, an endothelial cell count of more than 2000 cells/mm2 and internal anterior chamber depth (ACD) of more than 2.8 mm have been reported to be criteria for implantation of iris-fixated pIOLs. However, for implantation of any prosthesis in the anterior chamber, the critical distance between endothelium and prosthesis, known as endothelial clearance, would be better for evaluation than just the ACD.

In the case of the myopic Artisan pIOLs (Ophtec, Groningen, The Netherlands), the peripheral endothelial clearance (distance from endothelium to peripheral edge of the Artisan) seems to be more important than the ACD, and it has been suggested that it should be more than 1.5 mm. So, it seems to be important that we are able to predict this distance preoperatively.

Scheimpflug photography

Scheimpflug photography has been used preoperatively to simulate the position of pIOLs in the anterior chamber. Tehrani et al.1 used Scheimpflug photography for preoperative simulation of the pIOL position in the anterior chamber and reported the results in 1 case.

AS-OCT

Anterior segment optical coherence tomography (AS-OCT) is a useful imaging technique for internal biometry of the anterior chamber. The Visante AS-OCT system (Carl Zeiss Meditec, Jena, Germany) also has a software tool (pIOL template) to simulate the postoperative position of iris-fixated pIOLs and can be useful in evaluating its position preoperatively.

Recent Videos
Abdelrahman Elhusseiny, MD, MSc, discusses his AAO presentation on risk of posterior capsular rupture in fellow-eyes cataract surgery
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Marjorie Rah, OD, PhD, FAAO
Related Content
© 2024 MJH Life Sciences

All rights reserved.